Ganymede Stock

Ganymede is a low-code PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines.

Sign up today and learn more about Ganymede Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Ganymede Stock

Ganymede is a low-code bio-aware PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines. Ganymede allows software engineers to create integrations, link software and hardware, and move data around using easy versioning. Ganymede is headquartered in Palo Alto, California and was founded in 2022.

Funding History

April 2022$2.9M
August 2022$12.8M

Management

Co-Founder

Benson Lee

Board Member

Varun Gupta

Co-Founder

Nathan Clark

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo